Lycia Therapeutics is a biotechnology company that focuses on developing technology that utilizes lysosome-targeting chimeras.
Lycia Therapeutics is a biotechnology company that focuses on developing technology that utilizes lysosome-targeting chimeras. The company was founded by Carolyn R. Bertozzi in 2019 and is based in San Diego, California, USA.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 9, 2021 | Series B | $70M | 1 | — | — | Detail |
| Jun 9, 2020 | Series A | $50M | 1 |
Versant Ventures
|
— | Detail |
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Jul 28, 2021
Yield Guild Games
|
Initial Coin Offering | $12.50M | Blockchain | — |
|
May 5, 2021
BitPay
|
Secondary Market | — | Bitcoin | — |
|
Jan 30, 2021
Aave
|
Secondary Market | — | Blockchain | — |
|
Jul 1, 2020
Terra
|
Secondary Market | — | Blockchain | — |
|
Aug 30, 2018
Circle
|
Secondary Market | — | Banking | — |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Versant Ventures
|
— | Series B |